Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New online program aims to support korean breast cancer patients

NCT ID NCT07499089

Symptom relief Sponsor: Cedars-Sinai Medical Center Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study will test a culturally tailored online peer-support program for Korean-speaking breast cancer survivors and patients. Over 12 weeks, mentors (survivors) and mentees (patients in treatment) will interact through a bilingual platform. Researchers will measure whether the program is engaging and whether it improves quality of life, anxiety, depression, and social support.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
online peer-support program
What this could lead to
If successful, this could provide a culturally tailored support option to improve emotional well-being and social support for Korean breast cancer patients and survivors.
What could go wrong
This is a very small early-stage study (24 participants) focused on feasibility, so it may not show clear benefits or be generalizable to all Korean breast cancer survivors.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 24 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Apr 2026

An estimate. Start dates often move.

Expected to finish

Dec 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The study population consists of Korean American breast cancer patients and survivors. Participants include mentors (breast cancer survivors diagnosed at least two years prior and who have completed treatment or are on long-term maintenance therapy) and mentees (patients currently undergoing active breast cancer treatment). All participants are required to have access to a smartphone or computer and be able to participate in an online peer-support platform. Participants will be recruited through community outreach, referrals, and self-referral using a QR code-based screening process.

Ages

18 years and older

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Mentors: * Age ≥ 18 years * Self-identify as Korean * Able to read, write, and speak both Korean and English * Diagnosed with breast cancer ≥ 2 years prior to enrollment * Completed active treatment or currently on long-term maintenance therapy * Access to a smartphone, computer, or similar device compatible with the study platform * Willing to participate for at least 3 months * Willing to complete required training and surveys Mentees: * Age ≥ 18 years * Self-identify as Korean * Able to read, write, and speak Korean * Diagnosed with breast cancer * Currently receiving treatment (e.g., chemotherapy, radiation therapy, recent surgery, or endocrine therapy) * Access to a smartphone, computer, or similar device compatible with the study platform * Willing to participate for at least 3 months * Willing to complete required surveys Exclusion Criteria: * Individuals who do not meet the inclusion criteria * Individuals unable to use the online platform or required technology * Individuals deemed non-compliant or inappropriate for participation based on investigator judgment (e.g., inability to complete study procedures) * Mentees diagnosed with ductal carcinoma in situ (DCIS)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Breast cancer are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Breast cancer Breast cancer survivors

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Cedars Siani Cancer

    Los Angeles, California, 90048, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.